Cuba Lung Cancer Treatment

September 16, 2020

In 2012 Cuba patented the first therapeutic vaccine in the world against advanced lung cancer called CIMAVAX-EGF. CimaVax which is both a treatment and vaccine for lung cancer has been researched in Cuba for 25 years and free to the Cuban public since 2011.

3 Innovations Of The Cuban Lung Cancer Treatment Cimavax Egf Roswell Park Comprehensive Cancer Center

In January 2013 the island announced the second cancer vaccine known as Racotumomab VAXIRA.

Cuba lung cancer treatment. Patients is CIMAvax-EGF an immunotherapy for lung cancer. Doebele is concerned that if Keays. Oncology Program cancer treatment programs are available in Cuba.

Patients some of whom are already traveling there to try the drug in hopes of stopping their cancer from growing. PLEASE NOTE THE FOLLOWING IMPORTANT INFORMATION. Cimavax fights cancer by stimulating an immune response against a protein in the blood that triggers the growth of lung cancer.

The above program does not include medications for certain conditions such as. The drug CimaVax helps treat symptoms and recurrence said institute. But when the tale turns to Cubas development of a lung-cancer vaccine called CIMAvax that enhances the immunological approach with genetic engineering.

The patient is evaluated by multidisciplinary teams composed of internists radiologists pathologists hematologists. Roswell Park is opening a clinical trial to study the CIMAvax-EGF a cancer treatment that was developed in Cuba. This week the Roswell Park Cancer Institute of Buffalo New York signed an agreement to import a Cuban lung cancer vaccine.

After an induction period patients receive a. This treatment a type of immunotherapy that harnesses the bodys immune system will be used to treat patients with lung cancer the most common cause of cancer death worldwide. A Regina woman who was diagnosed with lung cancer and given a year to live says shes now in remission thanks to a vaccine she received in Cuba.

By 2013 Cuba biotechnology centers has 1200international patents including Nimotuzumab or CIMAher for head and neck cancer as well as the gastrointestinal GI tract cancer CIMAVAX-EGF and Racotumomab or Vaxira for non-small cell lung cancer. CIMAvax-EGF a therapeutic vaccine for non-small cell lung cancer NSCLC developed in Cuba consists of a human recombinant EGF able to induce antibodies against the autologous EGF resulting in serum EGF withdrawal and lower EGF-EGFR interaction. Roswell Parks Cuban Collaboration Through an historic partnership with Cubas Centro de Inmunología Molecular or CIM Roswell Park is helping to develop several innovative and potentially life-saving cancer therapies.

Historically there hasnt really been much to do other than try chemotherapy try radiation try some maybe targeted therapy and then. Racotumomab is the second vaccine for non-small cell lung cancer developed in Cuba after CimaVax-EGF. Cuba is well known for its cutting edge treatment of lung cancer and advances in cancer vaccines currently being tested in the United States.

The data collected has allowed the national and regional authorities to make appropriate decisions on how best to invest the scarce resources in cancer control to prevent diagnose and treat cancer particularly to plan and decide on an annual budget for oncology medicines cancer care facilities development and planning procuring and allocating radiotherapy equipment among other activities. The first of these new approaches to be available to US. The treatment this story highlights does indeed exist in Cuba.

One reason for that is that Keays is currently taking Tagrisso a standard therapy for non-small cell lung cancer. In the United States more people die every year of lung cancer than the other major cancers. A promising lung cancer treatment from Cuba is getting attention from US.

Its a therapy named CIMAvax used to treat lung cancer and which has begun being. Late stage lung cancer progresses very quickly.

Lung Cancer Treatment Program In Cuba Tours In Havana